Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia X, Gil A, Poveda-Andrés JL, Shepherd J, Tort M

Open source

DOI
10.7399/fh.11147
Published
2019 Jul 1
Container
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7399/fh.11147,
  title = {Analysing criteria for price and reimbursement of orphan drugs in Spain.},
  author = {Badia X and Gil A and Poveda-Andrés JL and Shepherd J and Tort M},
  year = {2019},
  journal = {Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria},
  doi = {10.7399/fh.11147},
  url = {https://doi.org/10.7399/fh.11147}
}

RIS

TY  - JOUR
TI  - Analysing criteria for price and reimbursement of orphan drugs in Spain.
AU  - Badia X
AU  - Gil A
AU  - Poveda-Andrés JL
AU  - Shepherd J
AU  - Tort M
PY  - 2019
JO  - Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
DO  - 10.7399/fh.11147
UR  - https://doi.org/10.7399/fh.11147
ER  - 

APA

X, B., A, G., JL, P., J, S., & M, T. (2019). Analysing criteria for price and reimbursement of orphan drugs in Spain.. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. https://doi.org/10.7399/fh.11147

Source records